Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study
Public ClinicalTrials.gov record NCT05430854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Extension Study To Evaluate The Long- Term Safety And Tolerability Of Daxdilimab (Hzn-7734) In Subjects With Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2, Open-Label Extension study to evaluate the long-term safety and tolerability of daxdilimab in participants with Systemic Lupus Erythematosus completing the treatment period of the RECAST SLE clinical study.
Study identification
- NCT ID
- NCT05430854
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 155 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 72 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2022
- Primary completion
- Oct 30, 2023
- Completion
- Oct 30, 2023
- Last update posted
- Sep 18, 2024
2022 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Inland Rheumatology Clinical Trials Incorporated | Upland | California | 91786 | — |
| Clinical Research of West Florida Inc - Clearwater | Clearwater | Florida | 33765-2616 | — |
| Millennium Research | Ormond Beach | Florida | 32174 | — |
| IRIS Research and Development LLC | Plantation | Florida | 33324 | — |
| Clinical Research of West Florida Inc - Tampa | Tampa | Florida | 33606-1246 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| Bluegrass Community Research Inc | Lexington | Kentucky | 40504-2931 | — |
| NYU Langone Ambulatory Care Brooklyn Heights | Brooklyn | New York | 11201 | — |
| DJL Clinical Research | Charlotte | North Carolina | 28210-8509 | — |
| Paramount Medical Research and Consulting LLC | Middleburg Heights | Ohio | 44130-3483 | — |
| Precision Comprehensive Clinical Research Solutions | Colleyville | Texas | 76034-5913 | — |
| Metroplex Clinical Research Center | Dallas | Texas | 75231 | — |
| Southwest Rheumatology Research, LLC | Mesquite | Texas | 75150 | — |
| Spectrum Medical, Inc | Danville | Virginia | 24541-1222 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05430854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2024 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05430854 live on ClinicalTrials.gov.